Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for PHARMAZEUTISCHE FORMULIERUNGEN MIT DAPAGLIFLOZIN-PROPYLENGLYCOL-HYDRAT
Details for 2008732695
Up to date per 13.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2008732695
Title / Product Name
PHARMAZEUTISCHE FORMULIERUNGEN MIT DAPAGLIFLOZIN-PROPYLENGLYCOL-HYDRAT
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2008732695
EP Publication Number
2139494
E-Number
1242301
Language
EN
PCT Number
US08057888
Publication Date
06.01.2010 A
11.03.2020 B1
Registration Date
11.03.2020
AT Publication Date
15.03.2020
Application Date
21.03.2008
Registration Number
-
Priorities
22.03.2007
US
896286 P
IPC
A61K 31/70 20060101AFI20190730BHEP
Maximum Duration of Protection
21.03.2028
Owner
AstraZeneca AB
151 85 Södertälje
SE
Representative
Representative
Häupl & Ellmeyer KG, Patentanwaltskanzlei
Mariahilfer Straße 50 (Eingang Kirchengasse 1)
1070 Wien
AT
Inventor
BINDRA, Dilbir, S.
1 Squibb Drive
New Brunswick, NJ 08903
US
DALI, Mandar, V.
1 Squibb Drive
New Brunswick, NJ 08903
US
PARAB, Prakash, V.
1 Squibb Drive
New Brunswick, NJ 08903
US
PATEL, Jatin, M.
1 Squibb Drive
New Brunswick, NJ 08903
US
TAO, Li
1 Squibb Drive
New Brunswick, NJ 08903
US
TEJWANI, Ravindra, W.
1 Squibb Drive
New Brunswick, NJ 08903
US
VATSARAJ, Nipa
1 Squibb Drive
New Brunswick, NJ 08903
US
WU, Yongmei
1 Squibb Drive
New Brunswick, NJ 08903
US
Information about Fees
Click here to load the fees